An Overview of Progress in Antisense Therapeutics
- 1 April 1998
- journal article
- research article
- Published by Mary Ann Liebert Inc in Antisense and Nucleic Acid Drug Development
- Vol. 8 (2) , 115-122
- https://doi.org/10.1089/oli.1.1998.8.115
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Inhibition of Coagulation by a Phosphorothioate OligonucleotideAntisense and Nucleic Acid Drug Development, 1997
- Comparison of the toxicity profiles of ISIS 1082 and ISIS 2105, phosphorothioate oligonucleotides, following subacute intradermal administration in Sprague-Dawley ratsToxicology, 1997
- Uptake Characteristics of Oligonucleotides in the Isolated Rat Liver Perfusion SystemAntisense and Nucleic Acid Drug Development, 1996
- Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administrationBiochemical Pharmacology, 1995
- Transport of phosphorothioate oligonucleotides in kidney: Implications for molecular therapyKidney International, 1995
- Use of Cationic Lipids to Enhance the Biological Activity of Antisense OligonucleotidesJournal of Liposome Research, 1993
- Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluidJournal of Biochemical and Biophysical Methods, 1990
- Characterization of oligonucleotide transport into living cells.Proceedings of the National Academy of Sciences, 1989
- Oligodeoxynucleotide stability in subcellular extracts and culture mediaJournal of Biochemical and Biophysical Methods, 1986
- Interferon Induction Increased through Chemical Modification of a Synthetic PolyribonucleotideScience, 1969